What issues can result from cross-contamination in sterile compounding?

Cross-contamination in sterile compounding can lead to patient infections, making this the correct choice. When sterile products are prepared in an environment where contamination occurs, harmful pathogens can inadvertently be introduced into the final compound. These pathogens may come from various sources, including surfaces, equipment, and even the personnel involved in the compounding process. If a contaminated preparation is then administered to a patient, it can lead to infections, which may cause serious health complications or prolong recovery times.

On the other hand, increased drug efficacy, improved sterility, and enhanced patient compliance are not issues that arise from cross-contamination. Cross-contamination undermines the sterility of compounded preparations, which is crucial for patient safety and drug effectiveness. Instead of improving conditions, cross-contamination poses risks that can negatively impact patient health and treatment outcomes.